Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2025 16:45 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces C$1 Million Non-Brokered Private Placement

TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis...
March 07, 2025 16:45 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces C$1 Million Non-Brokered Private Placement

TORONTO, March 07, 2025 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis...
December 29, 2023 17:00 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement

TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
December 15, 2023 17:00 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces C$2 Million Non-Brokered Private Placement

TORONTO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
May 30, 2023 10:35 ET | Source: Blueberries Medical Corp.

Blueberries Medical Reports Q1-2023

TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), a leading player in the cannabis industry...
April 24, 2023 16:18 ET | Source: Blueberries Medical Corp.

Blueberries Medical Reports 2022 Financial Results

TORONTO, April 24, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
November 28, 2022 17:00 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update

TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and...
August 25, 2022 17:51 ET | Source: Blueberries Medical Corp.

Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update

TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
July 29, 2022 09:19 ET | Source: Blueberries Medical Corp.

Blueberries Medical Announces the launch of new markets for its products, partnerships in agronomic operation and the Extension of Maturity Date of Convertible Debenture

TORONTO, July 29, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
May 30, 2022 17:23 ET | Source: Blueberries Medical Corp.

Blueberries Medical Reports 2022 Q1 Financial Results and Provides Corporate and Operations Update

TORONTO, May 30, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...

Next Page keyboard_arrow_right